Literature DB >> 35635588

Segmental resection with partial mesopancreatic and mesojejunal excision (pMME) for duodenal carcinoma of the third or fourth portion.

Ryota Ito1, Yoshihiro Mise1, Yu Takahashi2, Yosuke Inoue2, Fumihiro Kawano2, Haruka Tanaka1, Shoichi Irie1, Hirofumi Ichida1, Ryuji Yoshioka1, Akio Saiura3.   

Abstract

INTRODUCTION: Pancreatoduodenectomy is the standard procedure for duodenal carcinoma of the third or fourth portion. As an alternative option, we developed a novel segmental resection (SR) with partial mesopancreatic and mesojejunal excision (pMME) that enhances radicality. In this report, the surgical technique with video and outcomes are described.
METHOD: We performed SR with pMME on seven consecutive patients with third or fourth duodenal carcinoma between 2009 and 2021. We divided the procedure into four sections, including (1) wide Kocher's maneuver, (2) supracolic anterior artery-first approach, (3) dissection of the mesopancreas and mesojejunum, and (4) devascularization of the uncinate process and dissection of duodenum. RESULT: Median operative time was 348 min (range, 222-391 min), and median blood loss was 100 mL (range, 30-580 mL). Major complications of Clavien-Dindo classification grade 3a or more occurred in one patient. All patients achieved R0 resections with 10 mm or more proximal margin. Six cases (85%) were alive without recurrence.
CONCLUSION: We developed a radical and safe procedure of SR with pMME as an alternative and less invasive approach for duodenal carcinoma of the third or fourth portion.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Duodenal carcinoma; Limited resection; Mesopancreatic dissection; Partial resection; Segmental resection

Mesh:

Year:  2022        PMID: 35635588     DOI: 10.1007/s00423-022-02569-7

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   2.895


  16 in total

1.  Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.

Authors:  George A Poultsides; Lyen C Huang; John L Cameron; Richard Tuli; Leslie Lan; Ralph H Hruban; Timothy M Pawlik; Joseph M Herman; Barish H Edil; Nita Ahuja; Michael A Choti; Christopher L Wolfgang; Richard D Schulick
Journal:  Ann Surg Oncol       Date:  2011-12-14       Impact factor: 5.344

Review 2.  Total meso-pancreas excision: key point of resection in pancreatic head adenocarcinoma.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Hepatogastroenterology       Date:  2011 Jan-Feb

Review 3.  Mesopancreas is a misnomer: time to correct the nomenclature.

Authors:  Dhananjaya Sharma; Shuji Isaji
Journal:  J Hepatobiliary Pancreat Sci       Date:  2016-10-12       Impact factor: 7.027

4.  Long-term outcomes in patients with duodenal adenocarcinoma.

Authors:  Sang Yeup Lee; Jae Hoon Lee; Dae Wook Hwang; Song Cheol Kim; Kwang-Min Park; Young-Joo Lee
Journal:  ANZ J Surg       Date:  2013-05-08       Impact factor: 1.872

5.  Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach.

Authors:  Yosuke Inoue; Akio Saiura; Ryuji Yoshioka; Yoshihiro Ono; Michiro Takahashi; Junichi Arita; Yu Takahashi; Rintaro Koga
Journal:  Ann Surg       Date:  2015-12       Impact factor: 12.969

6.  A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.

Authors:  Michael J Overman; Chung-Yuan Hu; Scott Kopetz; James L Abbruzzese; Robert A Wolff; George J Chang
Journal:  Ann Surg Oncol       Date:  2011-12-21       Impact factor: 5.344

7.  Vascular Anatomy of Mesopancreas in Pancreatoduodenectomy Using an Intestinal Derotation Procedure.

Authors:  Masanori Sugiyama; Yutaka Suzuki; Tetsuya Nakazato; Masaaki Yokoyama; Masaharu Kogure; Ryota Matsuki; Nobutsugu Abe
Journal:  World J Surg       Date:  2020-10       Impact factor: 3.352

8.  Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?

Authors:  Taro Sakamoto; Akio Saiura; Yoshihiro Ono; Yoshihiro Mise; Yosuke Inoue; Takeaki Ishizawa; Yu Takahashi; Hiromichi Ito
Journal:  Ann Surg Oncol       Date:  2017-08-10       Impact factor: 5.344

9.  Outcome after surgical resection for duodenal adenocarcinoma in the UK.

Authors:  L Solaini; N B Jamieson; M Metcalfe; M Abu Hilal; Z Soonawalla; B R Davidson; C McKay; H M Kocher
Journal:  Br J Surg       Date:  2015-03-16       Impact factor: 6.939

10.  Surgical treatment of adenocarcinoma of the rectum.

Authors:  S Zaheer; J H Pemberton; R Farouk; R R Dozois; B G Wolff; D Ilstrup
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.